Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /600488
chevron_leftBack
Tianjin Tianyao Pharmaceuticals Co., Ltd. logo

Tianjin Tianyao Pharmaceuticals Co., Ltd.

600488
SSE: 600488 Delayed
5.70CNY -2.7%
0.8423 USD
As of 9 June 2026, Tianjin Tianyao Pharmaceuticals Co., Ltd. has a market cap of $944.23M USD, ranking #11033 globally and #3140 in China. It ranks #997 in the Healthcare sector, and #52 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
11033
Country Rank
3140
Sector Rank
997
Industry Rank
52
Key Stats
Market Cap
$944.23MUSD
6.4B CNY
Enterprise Value
$1.07BUSD
7.24B CNY
Revenue (TTM)
$402.93MUSD
2.73B CNY
EBITDA (TTM)
$81.64MUSD
552.45M CNY
Net Income (TTM)
$3.9MUSD
26.41M CNY
EBITDA Margin
20%
Profit Margin
1%
PE Ratio
239.4
PS Ratio
2.3
PB Ratio
1.6
EV/EBITDA
12.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Shuxiang Li open_in_new
Employees
2,884
Founded
1939
Website
tjpcty.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.7% -11% 35% 37% 39% 48%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
600488
天津天药药业股份有限公司 Class A
ISIN: CNE000001840
Shares Out.:
1.092B1 Shares Float: 453.517M2
TV:
SA:
YF:
GF:
BA:
MS:
5.70 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Tianjin Tianyao Pharmaceuticals Co., Ltd.

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company’s primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It exports its products to the United States, Southeast Asia, Europe, South America, Africa, and internationally. The company was founded in 1939 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)
Name
Market Cap diff.
PE
$15.84B
107.34B CNY
2K%
16.0
$9.09B
61.6B CNY
863%
80.6
$5.21B
35.33B CNY
452%
20.0
$4.2B
28.47B CNY
345%
20.8
$3.26B
22.12B CNY
246%
8.1
$2.74B
18.55B CNY
190%
11.5
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.17B
108.92B ILS
4K%
24.2
$29.56B
3K%
-
CIPLA
$11.16B
1.06T INR
1K%
23.4
LUPIN
$11.04B
1.05T INR
1K%
22.7
$8.72B
7.57B EUR
823%
-
AUROPHARMA
$8.46B
807.02B INR
796%
23.1
chevron_leftBack